Surrey researchers Sign in
Targeted therapy for advanced renal cell cancer: Cytokines and beyond
Journal article   Peer reviewed

Targeted therapy for advanced renal cell cancer: Cytokines and beyond

GS Papaetis, LM Karapanagiotou, H Pandha and KN Syrigos
CURRENT PHARMACEUTICAL DESIGN, Vol.14(22), pp.2229-2251
01/08/2008

Abstract

Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy PHARMACOLOGY & PHARMACY endothelium cytokines VEGF TGF-a m-TOR targeted therapy angiogenesis ENDOTHELIAL GROWTH-FACTOR PHASE-II TRIAL RECEPTOR TYROSINE KINASES LINDAU TUMOR-SUPPRESSOR HYPOXIA-INDUCIBLE FACTOR REFRACTORY SOLID TUMORS FACTOR-KAPPA-B GASTROINTESTINAL STROMAL TUMORS PROTEASOME INHIBITOR BORTEZOMIB INTERNAL TANDEM DUPLICATION
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259448000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy